Imara Inc. (the "Company") (Nasdaq: IMRA) today announced that it has commenced a proposed underwritten public offering of $50 million of shares of its common stock. All of the shares are being offered by the Company.
There is a U-shaped association for hemoglobin levels with risk for dementia, including Alzheimer disease, according to a study published online July 31 in Neurology.